Researchers are exploring the use of MRI-based radiomics models for pretreatment risk stratification of endometrial cancer. Studies are investigating the potential of these models to predict various aspects of the disease, including ki-67 expression levels and survival outcomes. The application of radiomics and artificial intelligence in oncology diagnosis is being examined in various types of cancer, including endometrial and cervical cancer.